semaglutide and tirzepatide for weight loss treatment leads to in type 1 diabetes GLP-1 Medications for Weight Loss:

Inadequate response to Wegovy

We have also identified gastrointestinal distension stimuli [53] and the rare sugar d-allulose [54] as non-caloric stimulators of GLP-1 release

& Schlessinger, J

This captures cases where side effects were severe enough to warrant stopping treatment entirely

While generally mild and reversible, physicians will be watching the safety data closely

After removing the base cap, placing the pen against the skin, unlocking, and pressing the injection button, patients should hold the pen in place until the injection is complete (indicated by a click and/or the window turning completely colored)